Selling Securities Clause Examples for Any Agreement

Selling Securities. 5.1 An instruction for the sale of Securities is an order from you for FitVermogen to sell (part of) the claims vis- à-vis the Giro administered on your FitVermogen Account. 5.2 An instruction for the sale of Securities will be denominated in the number of Securities to be sold. 5.3 If the Security in question is exclusively listed or available in a currency other than the euro, FitVermogen will execute the securities order at the rates applied by the Executing Institution on the day on which Fit- Vermogen executes the Securities Order in accordance with Article 5.5. 5.4 If FitVermogen has received a Securities Order for the sale of Securities from you before 13.15 p.m., FitVer- mogen will send the Securities Order for the sale of Securities, that same day, to the Stock Exchange or – in the event of non-listed Securities – the Issuing Institution. 5.5 If FitVermogen ascertains that your order was received at or after 1.15 p.m. but before 1.30 p.m., then FitVermogen will make every effort to send the order to the Stock Exchange, or – in the event of non-listed Securities – to the Issuing Institution on the same day. This is not a guarantee, however. 5.6 If FitVermogen has received a Securities Order for the sale of Securities from you at or after 1.30 p.m., FitVermogen will send the Securities Order for the sale of Securities to the Stock Exchange or – in the event of non-listed Securities – the Issuing Institution on the next business day. 5.7 In special cases FitVermogen reserves the right to bring forward the time at which the orders are sent to the Stock Exchange. This may be the case on 24 December or 31 December, for example. 5.8 If you send your Securities Order for the sale of Securities on a day that FitVermogen is not open, FitVermo- gen will send your Securities Order to the Stock Exchange, or – in the event of non-listed Securities – to the Issuing Institution on the next Trading Day on which FitVermogen is open. FitVermogen undertakes to continuously inform you about the days on which it is open and closed by means of publication on the Website. 5.9 A Securities Order for the sale of Securities will be executed on the next Trading Day following the day on which FitVermogen sent your Securities Order to sell Securities to the stock exchange or – in the event of non-listed securities – the Issuing Institution. Your Securities Order to sell Securities will be executed at the Stock Exchange price of the Trading Day following the day on which the or...
Source 1Source 2See All (7)
Selling Securities. 7.1 The Customer acknowledges that uncovered short‐selling is not allowed and for every sell order which involves Securities traded on the SEHK, the Customer shall at the time of placing the order have a presently exercisable and unconditional right to vest the Securities to which the order relates in the purchaser of those Securities. The Customer shall notify the Bank when a sell order relates to Securities which the Customer does not have such right prior to or at the time of the order. In the absence of any information to the contrary, the Bank may assume that the Customer has such right at all times. 7.2 The Customer hereby declares that every sell order of Securities traded on the SEHK that the Customer (whether as principal or agent) asks the Bank to execute will be a "long" sale, unless the Customer otherwise confirms to the Bank in writing or (if sent electronically) which is capable of being printed, that: (a) the order is a short selling order; (b) the Customer has a presently exercisable and unconditional right to vest the Securities to which the relevant sale order relates in the purchaser of those Securities; and (c) to the extent that the Customer has borrowed the Securities has obtained a confirmation from the lender that it has the Securities available to lend or deliver to the Customer. The Bank is entitled to refuse to accept any instruction for short sale if the Bank is not satisfied that the conditions referred to in this Clause 7.2 have been complied with. 7.3 Instructions for selling Securities will be accepted only if: (a) the Customer has deposited or transferred or has arranged for the deposit or transfer of the relevant Securities with or to the Bank, and instructions for the deposit or transfer of the relevant Securities with or to the Bank have been duly given; and (b) the Customer has duly signed or caused to be signed the Transfer Documents relating to such Securities. 7.4 The Bank may, notwithstanding Clause 7.3, accept in its discretion an instruction for sale of Securities prior to full compliance with the requirements of Clause 7.3. If the Customer fails to comply with the requirements of Clause 7.3 before the close of business of that Business Day following receipt of the instruction concerned, the Bank may (without obligation), in order to complete the sale, at any time thereafter without prior notice to the Customer (i) withdraw Securities of the same type held for the Customer, if any; or (ii) purchase an equal quanti...
Source 1
Selling Securities. Fidelity has provided the opportunity to liquidate securities held within baskets from two trade areas, Trade Stocks and Basket Trading. Because we display your total shares held in a stock on the Positions page with an indicator that some shares may be part of a basket, shares can be liquidated from the Trade Stocks screen and the Basket Trading application. If you own some or all shares of a security within a basket or multiple baskets, and are selling shares from the Trade Stocks screen, you will receive a message indicating that you may be breaking a basket position. If you sell outside the Basket Trading application, and are not liquidating your entire position, shares will first be sold from any shares not held in a basket. Additional shares needed to complete the sell order will be sold based on logic that has the least impact to the fewest number of baskets. If you are liquidating a position within the Basket Trading application, you will only be able to sell the shares within that specific basket. Section 7 of this agreement refers to your selection of tax lots when you specify specific shares on sell orders. Basket Trading provides functionality to establish and update orders in both shares and dollars. Orders are transmitted only in shares and the application rounds orders down to the nearest whole share.
Source 1

Related to Selling Securities

  • Underlying Securities The Company will reserve and keep available at all times, free of pre-emptive rights, shares of Common Stock for the purpose of enabling the Company to satisfy all obligations to issue the Underlying Securities upon conversion of the Securities. The Company will use its best efforts to cause the Underlying Securities to be listed on the Exchange.

  • Holding Securities The Custodian shall identify on its books as belonging to the Portfolios the foreign securities held by each Foreign Sub-Custodian or Foreign Securities System. The Custodian may hold foreign securities for all of its customers, including the Portfolios, with any Foreign Sub-Custodian in an account that is identified as belonging to the Custodian for the benefit of its customers, provided however, that (i) the records of the Custodian with respect to foreign securities of the Portfolios which are maintained in such account shall identify those securities as belonging to the Portfolios and (ii), to the extent permitted and customary in the market in which the account is maintained, the Custodian shall require that securities so held by the Foreign Sub-Custodian be held separately from any assets of such Foreign Sub-Custodian or of other customers of such Foreign Sub-Custodian.

  • Offered Securities The Offered Securities have been duly authorized and when issued and delivered against payment by the Underwriters pursuant to this Agreement, will be validly issued.

  • SELLING STOCKHOLDERS The common stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable to the selling stockholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see “Private Placement of Shares of Common Stock and Warrants” above. We are registering the shares of common stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants, the selling stockholders have not had any material relationship with us within the past three years. The table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by each selling stockholder, based on its ownership of the shares of common stock and warrants, as of ________, 2023, assuming exercise of the warrants held by the selling stockholder on that date, without regard to any limitations on exercise. The third column lists the shares of common stock being offered by this prospectus by the selling stockholders. In accordance with the terms of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale of the (i) sum of the number of shares of common stock issued to the selling stockholders in the “Private Placement of Shares of Common Stock and Warrants” described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus. Under the terms of the warrants, a selling stockholder may not exercise the warrants to the extent such exercise would cause such selling stockholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 9.99%, of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of such warrants which have not been exercised. The number of shares in the second and fourth columns do not reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering. See "Plan of Distribution." The undersigned owner of common stock and warrants to purchase common stock (such shares of common stock, the “Registrable Securities”) of Celularity Inc., a Delaware corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights Agreement”) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. Certain legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.

  • SELLING SHAREHOLDERS The common stock being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see "Private Placement of Common Shares and Warrants" above. We are registering the shares of common stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants, the selling shareholders have not had any material relationship with us within the past three years. The table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders. The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of the shares of common stock and warrants, as of ________, 2018, assuming exercise of the warrants held by the selling shareholders on that date, without regard to any limitations on exercises. The third column lists the shares of common stock being offered by this prospectus by the selling shareholders. In accordance with the terms of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number of shares of common stock issued to the selling shareholders in the __________________ and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus. Under the terms of the warrants, a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed [4.99]% of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of the warrants which have not been exercised. The number of shares in the second column does not reflect this limitation. The selling shareholders may sell all, some or none of their shares in this offering. See "Plan of Distribution." The undersigned beneficial owner of common stock (the “Registrable Securities”) of TheMaven, Inc., a Delaware corporation (the “Company”), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the “Registration Rights Agreement”) to which this document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. Certain legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.